Abstract
Treat rheumatoid arthritis (RA) to target (T2T) is an international initiative to provide the rheumatology community with clear direction on treatment targets for RA. We performed a nationwide survey in Korea among rheumatologists to measure the levels of agreement with international T2T recommendations and to assess their practical application in Korea. A questionnaire was administered to 111 physicians. Responses were assessed using a 10-point Likert scale for the level of agreement with each of 10 recommendations and a 4-point Likert scale for the degree to which each recommendation was being applied in current daily practice. Respondents were also asked whether these recommendations would result in a change in their practice. This report outlines the consensus reached for T2T in Korea and compares those results with data obtained internationally. Agreement with T2T recommendations was high with average response scores above 8.3. The majority of respondents indicated they applied the recommendations “always” and “very often” in daily practice. More than half of the participants not currently applying these recommendations were willing to change their practice, but the percentage of Korean physicians willing to change was consistently more than the international average. The results of this survey of T2T recommendations in Korean rheumatologists revealed a good correlation with the views of the international rheumatology community. These results could be utilized to define key issues for better disease control in daily practice and used as a reference to improve the treatment environment.
Similar content being viewed by others
References
Tehlirian CV, Bathon JM (2008) Rheumatoid arthritis. A. Clinical and laboratory manifestations. In: Klippel JH (ed) Primer on the rheumatic diseases. Springer, New York, pp 114–121
Pollard L, Choy EH, Scott DL (2005) The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol 23(suppl):S43–S52
Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK (1984) Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27:864–872
Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588
Oliver AM, St. Clair EW (2008) Rheumatoid arthritis. C. Treatment and assessment. In: Klippel JH (ed) Primer on the rheumatic diseases, 13th edn. Springer, New York, pp 133–141
Lard LR, Visser H, Speyer I et al (2001) Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 111:446–451
Grigor C, Capell H, Stirling A et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263–269
Verstappen SM, Jacobs JW, Van Der Veen MJ et al (2007) Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 66:1443–1449
Goekoop-Ruiterman YP, De Vries-Bouwstra JK, Allaart CF et al (2007) Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 146:406–415
Schoels M, Aletaha D, Smolen JS et al (2010) Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008. Ann Rheum Dis 69:575–578
Smolen JS, Aletaha D, Bijlsma JW et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69:631–637
Schoels M, Knevel R, Aletaha D et al (2010) Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis 69:638–643
Haraoui B, Smolen JS, Aletaha D et al (2011) Treating rheumatoid arthritis to target: multinational recommendations assessment questionnaire. Ann Rheum Dis 70:1999–2002
Felson DT, Smolen JS, WellS G et al (2011) American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 63:573–586
Acknowledgments
We thank the T2T Core Member Group: Seong-Wook Kang, Sung-Soo Kim, Sung-Il Kim, Jin Seok Kim, Hae-Rim Kim, Wan-Hee Yoo, Chang-Hee Seo, Seung-Cheol Shim, Shin-Seok Lee, Eun Young Lee, Ji-Soo Lee, Chang Keun Lee, Choong-Ki Lee, Won Tae Chung, Ji Hyeon Ju, Hoon-Suk Cha, Seong-Jae Choi, Jung-Yoon Choe, and Chan-Bum Choi. We thank the Korean College of Rheumatology for permitting the use of their website to enable the survey to be completed.
Disclosures
A draft of this manuscript was prepared by UBM Medica and supported financially by Abbott Korea and Eisai Korea. Abbott Korea and Eisai Korea did not take part in the actual preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, YB., Koh, EM., Kim, HY. et al. Treating rheumatoid arthritis to target: recommendations assessment questionnaire in Korea. Clin Rheumatol 32, 1791–1797 (2013). https://doi.org/10.1007/s10067-013-2365-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-013-2365-5